Diethylcarbamazine (DEC): immunopharmacological interactions of an anti-filarial drug.
about
Diethylcarbamazine activity against Brugia malayi microfilariae is dependent on inducible nitric-oxide synthase and the cyclooxygenase pathwayKilling filarial nematode parasites: role of treatment options and host immune responseHighlights of human toxocariasisTargeted killing of a mammalian cell based upon its specialized metabolic stateDiethylcarbamazine increases activation of voltage-activated potassium (SLO-1) currents in Ascaris suum and potentiates effects of emodepsideAn In Vitro/In Vivo Model to Analyze the Effects of Flubendazole Exposure on Adult Female Brugia malayiAdverse reactions following diethylcarbamazine (DEC) intake in 'endemic normals', microfilaraemics and elephantiasis patients.Examining the role of macrolides and host immunity in combatting filarial parasites.Extralymphatic disease due to bancroftian filariasis.How do the macrocyclic lactones kill filarial nematode larvae?The effect of oral anthelmintics on the survivorship and re-feeding frequency of anthropophilic mosquito disease vectorsA murine macrofilaricide pre-clinical screening model for onchocerciasis and lymphatic filariasisHistamine 1 Receptor Blockade Enhances Eosinophil-Mediated Clearance of Adult Filarial WormsNovel microfilaricidal activity of nanosilver.Anthelmintics: The best way to predict the future is to create it.Human Leukocytes Kill Brugia malayi Microfilariae Independently of DNA-Based Extracellular Trap Release.Mathematical models for lymphatic filariasis transmission and control: Challenges and prospects.Current practices in the management of lymphatic filariasis.Diethylcarbamazine attenuates the development of carrageenan-induced lung injury in miceTowards novel antifilarial drugs: challenges and recent developments.Progress and challenges in the discovery of macrofilaricidal drugs.Diethylcarbamazine: possible therapeutic alternative in the treatment of alcoholic liver disease in C57BL/6 mice.Inducible nitric oxide synthase/CD95L-dependent suppression of pulmonary and bone marrow eosinophilia by diethylcarbamazine.Diethylcarbamazine reduces chronic inflammation and fibrosis in carbon tetrachloride- (CCl₄-) induced liver injury in mice.Control of human filarial vector, Culex quinquefasciatus Say 1823 (Diptera: Culicidae) through bioactive fraction of Cayratia trifolia leaf.Roles of 5-lipoxygenase and cysteinyl-leukotriene type 1 receptors in the hematological response to allergen challenge and its prevention by diethylcarbamazine in a murine model of asthma.The function of two P450s, CYP9M10 and CYP6AA7, in the permethrin resistance of Culex quinquefasciatus.Characterization of rat spleen prostaglandin H D-isomerase as a sigma-class GSH transferase.Purification and characterization of prostaglandin-H E-isomerase, a sigma-class glutathione S-transferase, from Ascaridia galli.[Recommendations for the treatment of bancroftian filariasis in symptomless and diseased patients].Effect of Diethylcarbamazine (DEC) on prostaglandin levels in Wuchereria bancrofti infected microfilaraemics.An automated high-throughput system for phenotypic screening of chemical libraries on C. elegans and parasitic nematodes.Larval Age and Nutrition Affect the Susceptibility of Culex quinquefasciatus (Diptera: Culicidae) to Temephos.
P2860
Q24815903-80AA6C05-6A60-4BE3-B0AC-40F377C4CCE5Q28074470-54545265-12FD-4345-9600-83A91FFA44B1Q28362535-62BB15DC-438E-4C24-86C0-864EDE045DA1Q28511658-D839A8CE-8A46-45B7-8CF5-5EDAC9D786F6Q28545077-8147F1E7-6988-49B3-BFCF-E13DFF510A6BQ28551796-DAEF9F64-C859-4D48-AA6D-03709CCE3B59Q30775994-EBF6D782-BCD3-4350-9577-C5FC51A4F117Q33564559-D1B0589E-B447-4665-B249-5222C8A65E1BQ33786946-C551BE59-7D17-4572-94A5-71744722682FQ33805501-F9690898-BC45-45FA-B403-3EE24B04715EQ34126869-38195425-F5D0-413E-A4FE-7F3C6F6E848CQ34416898-51387778-7274-4DEA-A375-5B8CCC99145AQ35708452-7E8C3717-2688-4ABA-9835-7A7CF42B2E59Q35787492-9F655C23-2D9F-4120-B3AA-6925DD6F1D03Q35931413-E6BB798D-7983-4CF3-AB2A-968B68C45A48Q36237787-B251E517-EAC9-4E42-BA20-FF35B3FF08BEQ36509658-07481DB3-5D90-4B92-8F10-67ECC348218DQ37503357-68FF3648-5FD1-4CED-885F-58CC0B909DD2Q37557146-3FED67B5-5E22-4D27-9607-0DA699B796BEQ37855918-9CBCD9DC-2913-41EB-AB2D-5AAF6A7EFA88Q37912232-73E43B11-3CBC-4FC4-8DC3-92249DA92C78Q39039913-1264689E-718D-42B8-B3AC-2C736A9B6E48Q39374853-18BA2F49-6329-48BE-B4A4-30FE960815CFQ41889295-26B3D563-5D01-4C37-A689-97FDD9C6FDCEQ41891660-6D4F508E-3817-443B-B3B7-AA745BCDFE64Q42091483-9066E063-ADF5-40C7-BC06-B4694428166AQ42273235-25A96478-CE0D-4FEC-93AD-B2A9A4DDDC2AQ42822308-77F57BCE-12EF-477D-B73B-A95D2B921432Q42980507-E3AFEBD3-927A-4AF4-AFA7-8A22EECB5932Q43902005-D3CCD987-F71E-4FE2-9562-6A8606C0104CQ43960251-C5D8B7B7-4D60-43D0-AE97-A355CC31ECD1Q47177309-EF678576-479B-4CA6-9116-516672DA9227Q55228915-7C918B19-D5D9-4E22-9C58-6712960A410E
P2860
Diethylcarbamazine (DEC): immunopharmacological interactions of an anti-filarial drug.
description
1992 nî lūn-bûn
@nan
1992 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1992 թվականի հունվարին հրատարակված գիտական հոդված
@hy
1992年の論文
@ja
1992年論文
@yue
1992年論文
@zh-hant
1992年論文
@zh-hk
1992年論文
@zh-mo
1992年論文
@zh-tw
1992年论文
@wuu
name
Diethylcarbamazine (DEC): immunopharmacological interactions of an anti-filarial drug.
@ast
Diethylcarbamazine (DEC): immunopharmacological interactions of an anti-filarial drug.
@en
type
label
Diethylcarbamazine (DEC): immunopharmacological interactions of an anti-filarial drug.
@ast
Diethylcarbamazine (DEC): immunopharmacological interactions of an anti-filarial drug.
@en
prefLabel
Diethylcarbamazine (DEC): immunopharmacological interactions of an anti-filarial drug.
@ast
Diethylcarbamazine (DEC): immunopharmacological interactions of an anti-filarial drug.
@en
P2860
P1433
P1476
Diethylcarbamazine (DEC): immunopharmacological interactions of an anti-filarial drug.
@en
P2093
D A Denham
R M Maizels
P2860
P304
P356
10.1017/S0031182000075351
P478
P577
1992-01-01T00:00:00Z